Genistein

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameGenistein
Drug Alias Name4',5,7-Trihydroxyisoflavone染料木碱染料木素染料木黄酮染料森黄酮 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsTopoisomerase II inhibitorsProtein-tyrosine kinases inhibitors
TargetsTopoisomerase IIProtein-tyrosine kinases
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Skin MelanomaSolid tumours +[47] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSlovenia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesLondon Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sArmed Forces Radiobiology Research InstituteWestern University +[8] 
Inactive CompaniesUman PharmaFederal University Of Sao PauloThe University Of California Davis +[12] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Post-Acute COVID-19 SyndromeAcute Radiation Syndrome +[10] 
Inactive IndicationsSkin MelanomaSolid tumoursMenopausal symptoms +[37] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank